SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported):  August 14, 2003

PROTEIN DESIGN LABS, INC.

(Exact name of registrant as specified in its charter)

 

 

Delaware		000-19756		94-3023969
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

 

 

 

 

 

Not Applicable
(Former name or former address, if changed since last report)

 

 

 

Item 7.  Financial Statements and Exhibits

 

(c)  Exhibits

 

                99.1         Press Release dated August 14, 2003.

 

Item 12.  Results of Operations and Financial Condition.

 

On August 14, 2003, Protein Design Labs, Inc. (“PDL”) announced an adjustment in its financial results for the quarter ended June 30, 2003.  A copy of PDL’s press release is attached hereto as Exhibit 99.1.

 

The information furnished in this Item 12 and Exhibit 99.1 attached hereto shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 or 12(a)(2) of the Securities Act of 1933, as amended. The information contained herein and in the accompanying exhibit shall not be deemed to be incorporated by reference into any filing with the SEC made by PDL whether before or after the date hereof, regardless of any general incorporation language contained in such filing.

 

 

 

2

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

Date:  August 14, 2003	PROTEIN DESIGN LABS, INC.
	By:	/s/ Glen Sato
		Glen Sato
		Senior Vice President and Chief Financial Officer

 

 

3

 

EXHIBIT INDEX

 

Exhibit No.		Description
99.1		Press Release dated August 14, 2003.

 

 

4